Regulation of ligands for the NKG2D activating receptor. 2013

David H Raulet, and Stephan Gasser, and Benjamin G Gowen, and Weiwen Deng, and Heiyoun Jung
Department of Molecular and Cell Biology and Cancer Research Laboratory, University of California, Berkeley, California 94720-3200, USA. raulet@berkeley.edu

NKG2D is an activating receptor expressed by all NK cells and subsets of T cells. It serves as a major recognition receptor for detection and elimination of transformed and infected cells and participates in the genesis of several inflammatory diseases. The ligands for NKG2D are self-proteins that are induced by pathways that are active in certain pathophysiological states. NKG2D ligands are regulated transcriptionally, at the level of mRNA and protein stability, and by cleavage from the cell surface. In some cases, ligand induction can be attributed to pathways that are activated specifically in cancer cells or infected cells. We review the numerous pathways that have been implicated in the regulation of NKG2D ligands, discuss the pathologic states in which those pathways are likely to act, and attempt to synthesize the findings into general schemes of NKG2D ligand regulation in NK cell responses to cancer and infection.

UI MeSH Term Description Entries
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016692 Receptors, Antigen, T-Cell, gamma-delta T-cell receptors composed of CD3-associated gamma and delta polypeptide chains and expressed primarily in CD4-/CD8- T-cells. The receptors appear to be preferentially located in epithelial sites and probably play a role in the recognition of bacterial antigens. The T-cell receptor gamma/delta chains are separate and not related to the gamma and delta chains which are subunits of CD3 (see ANTIGENS, CD3). Antigen Receptors, T-Cell, gamma-delta,T-Cell Receptors delta-Chain,T-Cell Receptors gamma-Chain,T-Cell Receptors, gamma-delta,TcR gamma-delta,Antigen T Cell Receptor, delta Chain,Antigen T Cell Receptor, gamma Chain,Receptors, Antigen, T Cell, gamma delta,T Cell Receptors, gamma delta,T-Cell Receptor delta-Chain,T-Cell Receptor gamma-Chain,T-Cell Receptor, gamma-delta,T Cell Receptor delta Chain,T Cell Receptor gamma Chain,T Cell Receptor, gamma delta,T Cell Receptors delta Chain,T Cell Receptors gamma Chain,TcR gamma delta,delta-Chain, T-Cell Receptor,delta-Chain, T-Cell Receptors,gamma-Chain, T-Cell Receptor,gamma-Chain, T-Cell Receptors,gamma-delta T-Cell Receptor,gamma-delta T-Cell Receptors,gamma-delta, TcR
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D055611 Natural Killer T-Cells A specialized subset of T-LYMPHOCYTES that exhibit features of INNATE IMMUNITY similar to that of NATURAL KILLER CELLS. They are reactive to glycolipids presented in the context of the major histocompatibility complex (MHC) class I-like molecule, CD1D ANTIGEN. Invariant Natural Killer T Cell,iNKT Cell,Invariant Natural Killer T-Cells,NKT Cell,NKT Cells,Natural Killer T-Cell,iNKT Cells,Cell, iNKT,Cells, iNKT,Invariant Natural Killer T Cells,Killer T-Cell, Natural,Killer T-Cells, Natural,Natural Killer T Cell,Natural Killer T Cells,T-Cell, Natural Killer,T-Cells, Natural Killer
D055655 NK Cell Lectin-Like Receptor Subfamily K An activating NK cell lectin-like receptor subfamily that regulates immune responses to INFECTION and NEOPLASMS. Members of this subfamily generally occur as homodimers. CD314 Antigen,Killer Cell Lectin-Like Receptor Subfamily K,Killer Cell Lectin-Like Receptor Subfamily K, Member 1,NK Cell Lectin-Like Receptor Subfamily K, Member 1,NK Cell Receptor D,NKG2-D Receptor,NKG2D Receptor,Antigen, CD314,Killer Cell Lectin Like Receptor Subfamily K,Killer Cell Lectin Like Receptor Subfamily K, Member 1,NK Cell Lectin Like Receptor Subfamily K,NK Cell Lectin Like Receptor Subfamily K, Member 1,NKG2 D Receptor,Receptor, NKG2-D,Receptor, NKG2D

Related Publications

David H Raulet, and Stephan Gasser, and Benjamin G Gowen, and Weiwen Deng, and Heiyoun Jung
August 2007, Immunology,
David H Raulet, and Stephan Gasser, and Benjamin G Gowen, and Weiwen Deng, and Heiyoun Jung
March 2009, Blood,
David H Raulet, and Stephan Gasser, and Benjamin G Gowen, and Weiwen Deng, and Heiyoun Jung
December 2008, Cellular & molecular immunology,
David H Raulet, and Stephan Gasser, and Benjamin G Gowen, and Weiwen Deng, and Heiyoun Jung
February 2021, Viruses,
David H Raulet, and Stephan Gasser, and Benjamin G Gowen, and Weiwen Deng, and Heiyoun Jung
June 2008, Medical microbiology and immunology,
David H Raulet, and Stephan Gasser, and Benjamin G Gowen, and Weiwen Deng, and Heiyoun Jung
January 2014, Frontiers in immunology,
David H Raulet, and Stephan Gasser, and Benjamin G Gowen, and Weiwen Deng, and Heiyoun Jung
April 2014, Science translational medicine,
David H Raulet, and Stephan Gasser, and Benjamin G Gowen, and Weiwen Deng, and Heiyoun Jung
January 2016, Current drug targets,
David H Raulet, and Stephan Gasser, and Benjamin G Gowen, and Weiwen Deng, and Heiyoun Jung
August 2003, Blood,
David H Raulet, and Stephan Gasser, and Benjamin G Gowen, and Weiwen Deng, and Heiyoun Jung
November 2019, Journal of reproductive immunology,
Copied contents to your clipboard!